Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine

Mechlorethamine hydrochloride

Drug class: Alkylating Drug

The FDA’s “Established Pharmacologic Class”: the group of medicines that work in a similar way.

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Mechlorethamine hydrochloride used for?
The FDA-approved label (Valchlor, Helsinn Therapeutics (U.S.), Inc., November 20, 2024) says: “VALCHLOR is indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy. VALCHLOR is an alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Mechlorethamine hydrochloride have a boxed warning?
No. None of the 1 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Mechlorethamine hydrochloride?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Mechlorethamine hydrochloride been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Mechlorethamine hydrochloride?
1 company lists prescription products of Mechlorethamine hydrochloride in the FDA NDC Directory, including Helsinn Therapeutics (U.S.), Inc..

What Mechlorethamine hydrochloride is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

VALCHLOR is indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy. VALCHLOR is an alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.

— FDA label: Valchlor, Helsinn Therapeutics (U.S.), Inc., effective November 20, 2024. Read the full label on DailyMed →

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

Forms and how it is given

Dosage formsGel
RouteTopical
Prescription products1 in the FDA NDC Directory
Brand namesValchlor

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA202317
VALCHLOR
HelsinnAugust 23, 2013 8, latest May 1, 2020
2020: Labeling · 2020: Labeling · 2016: Manufacturing (CMC)

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

RxCUI (RxNorm)1437711, 1437713
SPL set ID of the quoted label6a52e4c2-6a9f-4ebb-bc77-046b4f8bcd57
FDA labels (SPL)1
FDA applicationsNDA202317
Active ingredients (FDA)MECHLORETHAMINE

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Valchlor, Helsinn Therapeutics (U.S.), Inc., effective November 20, 2024; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers